Stock listing

Zevra Therapeutics, Inc.

Selected listing: 1GDA · DUS · EUR · DE

Zevra Therapeutics, Inc. (Dusseldorf:1GDA), Health Technology. Latest release Sep 2, 2026: Zevra Therapeutics to Present at Upcoming Investor Conferences.

1GDA:DUSEURDEUpdated September 25, 2026

Ticker: Dusseldorf:1GDA
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Dusseldorf
Currency: EUR

Latest news from Zevra Therapeutics, Inc.

Zevra Therapeutics to Present at Upcoming Investor Conferences

September 2, 2026

Zevra Therapeutics to Present New Long-Term Real-World Data on MIPLYFFA® in Niemann-Pick Disease Type C (NPC) at the 2026 SSIEM Annual Symposium

August 25, 2026

Zevra Reports Second Quarter 2026 Financial Results and Corporate Update

August 5, 2026

Zevra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference

August 4, 2026

Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) in Niemann-Pick Disease Type C (NPC)

August 3, 2026

All Zevra Therapeutics, Inc. news →

Events

Replays

Zevra Therapeutics, Inc. (ZVRA) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 04:30 PM ET
Watch
Zevra Therapeutics, Inc. (ZVRA) Q1 2026 Earnings Call
Wed, May 06, 2026 · 04:30 PM ET
Watch
Zevra Therapeutics, Inc. (ZVRA) Q4 2025 Earnings Call
Mon, Mar 09, 2026 · 04:30 PM ET
Watch

Research Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc. company profile

View the public company page for Zevra Therapeutics, Inc. on 6ix.

Zevra Therapeutics, Inc. news

Read company news and market updates connected to Zevra Therapeutics, Inc..

Zevra Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Zevra Therapeutics, Inc..